Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

MHRA cracks down on nasal decongestants

  • Comment
Pseudophedrine and ephedrine contained in nasal decongestants and cold and flu remedies are to have tighter controls, the medicines and drugs regulator has announced.

Pseudophedrine and ephedrine contained in nasal decongestants and cold and flu remedies are to have tighter controls, the medicines and drugs regulator has announced.

The Medicines and Healthcare products Regulatory Agency (MHRA) says a public consultation showed increasing concern about the potential for the drugs to be used in the illegal manufacture of methylamphetamine (crystal meth).

The MHRA is acting following a ruling by the Commission of Human Medicines, which conducted the consultation that ended in June.

The CHM ruled large packs of pseudoephedrine and ephedrine will be replaced by small packs of 720mg, the equivalent of 12 60mg tablets or 24 30mg capsules.

Sale of the drugs must be carried out by a pharmacist and they will be reclassified from pharmacy only to prescription only.

Dr June Raine, MHRA director of vigilance and risk management of medicines, said: 'The MHRA is introducing these measures to protect the public health following concern that was highlighted during the consultation process.'

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.